**Author details**

Jekaterina Erenpreisa<sup>1</sup> \*, Kristine Salmina1 and Mark Steven Cragg<sup>2</sup>

\*Address all correspondence to: katrina@biomed.lu.lv

1 Tumour Cell Biology Group, Latvian Biomedical Research and Study Centre, Riga, Latvia

2 Antibody and Vaccine Group, Cancer Sciences Unit, Faculty of Medicine, General Hospital, University of Southampton, Southampton, United Kingdom
